Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 21, 2011

Premium

Regulus Therapeutics has named Neil Gibson as its CSO.

Gibson was most recently CSO and head of oncology at Pfizer's oncology research unit. Before that, he held various positions, including CSO, at OSI Pharmaceuticals.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.